- Home
- NTRB vs CFSB Comparison
NTRB vs CFSB Comparison
Compare NTRB & CFSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- CFSB
- Stock Information
- Founded
- NTRB 2016
- CFSB 1889
- Country
- NTRB United States
- CFSB United States
- Employees
- NTRB N/A
- CFSB N/A
- Industry
- NTRB Industrial Specialties
- CFSB Major Banks
- Sector
- NTRB Health Care
- CFSB Finance
- Exchange
- NTRB Nasdaq
- CFSB Nasdaq
- Market Cap
- NTRB 59.1M
- CFSB 51.6M
- IPO Year
- NTRB N/A
- CFSB N/A
- Fundamental
- Price
- NTRB $7.50
- CFSB $13.70
- Analyst Decision
- NTRB Buy
- CFSB
- Analyst Count
- NTRB 1
- CFSB 0
- Target Price
- NTRB $13.00
- CFSB N/A
- AVG Volume (30 Days)
- NTRB 82.0K
- CFSB 18.7K
- Earning Date
- NTRB 05-30-2025
- CFSB 07-29-2025
- Dividend Yield
- NTRB N/A
- CFSB N/A
- EPS Growth
- NTRB N/A
- CFSB N/A
- EPS
- NTRB N/A
- CFSB N/A
- Revenue
- NTRB $2,398,437.00
- CFSB $7,484,000.00
- Revenue This Year
- NTRB $560.75
- CFSB N/A
- Revenue Next Year
- NTRB $588.39
- CFSB N/A
- P/E Ratio
- NTRB N/A
- CFSB N/A
- Revenue Growth
- NTRB 18.92
- CFSB N/A
- 52 Week Low
- NTRB $3.72
- CFSB $6.34
- 52 Week High
- NTRB $11.78
- CFSB $13.78
- Technical
- Relative Strength Index (RSI)
- NTRB 59.79
- CFSB 89.63
- Support Level
- NTRB $7.00
- CFSB $13.68
- Resistance Level
- NTRB $7.90
- CFSB $13.70
- Average True Range (ATR)
- NTRB 0.66
- CFSB 0.03
- MACD
- NTRB -0.01
- CFSB -0.19
- Stochastic Oscillator
- NTRB 37.45
- CFSB 100.00
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.